Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia

Journal of the Neurological Sciences

Volumn 141, Issue 1-2, 1996, Pages 59-64

  Mielke, R ^a,b   Kittner, B ^c   Ghaemi, M ^a,b   Kessler, J ^a,b   Szelies, B ^a,b   Herholz, K ^a,b   Heiss, W D ^a,b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c SANOFI   (France)

Author keywords

Positron emission tomography; Propentofylline; Regional cerebral metabolism; Vascular dementia

Indexed keywords

PROPENTOFYLLINE;

ADULT; AGED; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE UTILIZATION; HUMAN; MALE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030587553     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00127-X     Document Type: Article

References (31)

1. Banati, R.B., Schubert, P., Rothe, G., Gehrmann, J., Rudolphi, K., Valet, G. and Kreutzberg, G.W. (1994) Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by HWA 285. J. Cereb. Blood Flow Metab., 14: 145-149.
2. Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975). "Mini-Mental-State" - a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12: 189-198.
3. Goto, M., Demura, N. and Sakaguchi, T. (1987) Effects of propentofylline on disorder of learning and memory in rodents. Japan. J. Pharmacol., 45: 373-378.
4. Grome, J.J., Rudolphi, K. and Harper, A.M. (1985) Cerebrovascular effects of a xanthine derivative propentofylline (HWA 285). Drug Development Res., 5: 111-121.
5. Hachinski, V.C., Lassen, N.A., Marshall, J. (1974) Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet, 2: 207-210.
6. Hachinski, V.C., Linnette, D.I., Zilhka, E., DuBoulay, G.H., McAllister, V.L., Marshall, J., Russell, R.W.R. and Symon, L. (1975) Cerebral Blood Flow in dementia, Arch. Neurol., 32: 632-637.
7. Hefti, F., Dravid, A. and Hartikka, J. (1984) Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res., 293: 305.
8. Heiss, W.D., Hebold, I., Klinkhammer, P., Ziffling, P., Szelies, B., Pawlik, G. and Herholz, K. (1988) Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. J. Cereb. Blood Flow Metab., 8: 613-617.
9. Hirata, H., Ogawa, N., Haba, K., Asanuma, M., Chou, H. and Mori A. (1992) Effect of HWA 285 on ischaemia-induced loss of muscarinic cholinergic receptor binding in the gerbil hippocampus. Res. Commun Chem. Pathol. Pharmacol., 75: 365-368.
10. Huber, M., Kittner, B., Hojer, C., Fink, G., Neveling, M. and Heiss, W.D. (1993) Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke J. Cereb. Blood Flow Metab., 13: 526-530.
11. Hudlicka, O., Komarek, J. and Wright, A.J.A. (1981) The effect of a xanthine derivative. 1-(5′oxohexyl)-3-methyl-7-propylaxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits. Br. J. Pharmacol., 72: 723-730.
12. Kadoya, F., Mitani, A., Arai T, Kataoka K. (1992) Effects of HWA 285 on hypoxia-hypoglycaemia-induced calcium accumulation in gerbil hippocampal slices. J. Cereb. Blood Flow Metab., 12: 301-305.
13. Kessler, J., Schaaf, A. and Mielke, R. (1993) Fragmentierter Bildertest (FBT). Hogrefe Verlag für Psychologie, Göttingen.
14. Kindy, M.S., Bhat, A.N., Bhat, N.R. (1992) Transient ischaemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. Molec. Brain Res., 13: 199-206.
15. Kromer, L.F. (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science, 235: 214-216.
16. Marcusson, J. and European propentofylline study (1995) HWA 285 for the treatment of dementia - results of a 12 months clinical trial. J. Cereb. Blood Flow Metab., 15 (Suppl.1): 107.
17. Matsui, T. and Hirano, A. (Eds.) (1978) An atlas of the human brain for computerized tomography. Fischer, Stuttgart Tokyo New York.
18. Mielke, R., Herholz, K., Grond, M., Kessler, J. and Heiss, W.D. (1992) Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch. Neurol., 49: 909-913.
19. Mielke, R., Herholz, K., Grond, M., Kessler, J. and Heiss, W.D. (1994) Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia, 5: 36-41.
20. Mobley, W.C., Rutkowski, J.L., Tennekoon, G.I., Buchanan, K. and Johnston, M.V. (1985) Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science, 229: 284-287.
21. Nabeshima, T., Nitta, A. and Hasegawa, T. (1993) Impairment of learning and memory and the accesory symptoms in aged rats as senile dementia model: oral administration of HWA 285 produces recovery of reduced NGF content in the brain of aged rats. Jpn. J. Psychopharmacol., 13: 89-95.
22. Nagasawa, H., Kogure, K., Kawashima, K., Ido, T., Itoh, M. and Hatazawa, J. (1990) Effects of co-dergocrine mesylate (Hydergine®) in multi-infarct dementia as evaluated by positron emission tomography. Tohoku J. Exp. Med., 162: 225-233.
23. Oswald, W.D. (1979) Psychometrische Verfahren und Fragebögen für gerontopsychologische Untersuchungen. Z. Gerontol., 12: 341-350.
24. Parkinson, F.E., Rudolphi, K.A. and Fredholm, B.B. (1994) HWA 285: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmac., 25: 1053-1058.
25. Saletu, B., Möller, H.J., Grünberger, J., Deutsch, H. and Rössner M. (1990) Propentofylline in adult-onset cognitive disorders: double-blind, placebo controlled, clinical, psychometric and brain mapping studies. Neuropsychobiology, 24: 173-184.
26. 31P nuclear magnetic resonance spectroscopy. Arzneimittelforschung/Drug Res., 39: 886-889.
27. Schaaf, A., Kessler, J., Grond, M. and Fink, G. (1992) Memo Test. Ein verbaler Gedächtnistest nach der Methode des selektiven Erinnerns. Beltz-Test-Verlag, Weinheim.
28. Shinoda, I., Fukura, Y. and Fukura, S. (1990) Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol., 39: 1813-1816.
29. Yamada, Y., Nakamura, H. and Okada, Y. (1994) HWA 285 enhances the formation of long-term potentiation in guinea pig hippocampal slices. Neurosci. Lett., 176: 189-192.
30. Wienhard, K., Pawlik, G., Herholz, K., Wagner, R. and Heiss, W.D. (1985) Estimation of local cerebral glucose utilization by positron emission tomography of (18F)-2-fluoro-2-deoxy-D-glucose: A critical appraisal of optimization procedures. J. Cereb. Blood Flow Metab., 5: 115-125.
31. Wienhard, K., Eriksson, L., Grootonk, S., Casey, M., Pietrzyk, U. and Heiss, W.D. (1992) Performance evaluation of the positron scanner ECAT EXACT. J Comput. Assist. Tomogr., 16: 804-813.